App based biofeedback reduces migraine frequency in Norwegian study

Researchers in Norway tested a mobile app and sensor system to help adults with episodic migraine manage their symptoms without medication.

The study, published in the journal Cephalalgia, involved 279 participants who were divided into a treatment group and a waiting list group. Participants in the treatment group used two wireless sensors and a mobile app for ten minutes every day over a period of twelve weeks. The sensors measured physiological data including skin temperature, pulse variation, and muscle tension.

Users practiced using their breathing to influence these physical signals in real time to reduce stress and improve concentration. The study found that the biofeedback group experienced one fewer migraine day per month on average than the waiting list group. Researchers also noted that participants reported a better quality of life and used fewer standard painkillers.

While the treatment was not compared directly to medications, doctors suggested it could serve as a safe supplement for patients, particularly women of childbearing age who may avoid certain preventive drugs. The study was conducted across four Norwegian hospitals, including Haukeland universitetssykehus and St. Olavs hospital. Researchers noted that the most consistent reduction in migraine days occurred among participants who completed most of the daily sessions.

Although the technology is not yet certified as a medical device for migraines, the results suggest it offers a way for patients to manage symptoms at home without constant hospital visits.